China-UK Cancer Conference 2016 is held in Beijing, China
1 Mehefin 2016
Following the success of the China-United Kingdom Cancer (CUKC) Conference 2015 in Wales, the CUKC Conference 2016 was held in May in Beijing, China.
Attendees from across the UK, China and beyond benefitted from the opportunity to listen to elite speakers and network with distinguished representatives including world-leading researchers, clinicians, academics, scientists and students. The conference, which focused on discussing all areas of cancer research and cancer therapies, enabled like-minded individuals to share knowledge and professional experience.
The broad spectrum of themes included sessions on ‘Management of Familial Cancers’, ‘Palliative Care’, ‘Tips and Pitfalls for Gastrectomy’ and ‘The East Asian Forum for Clinical Trials.’ The english session included individual presentations on, ‘The Role of DKK-1 in the Osteoblastic Phenotype of Prostate Cancer Metastases’ (Dr Liam Morgan, Cardiff University), ‘NHERF1 Inhibits Malignant Phenotypes of Colorectal Cancer Cells through the Regulation of VEGFVEGFR2 Signalling Pathway’ (Yanan Gu, Capital Medical University) and ‘MicroRNA-1 Suppression in Gastric Cancer Promotes Angiogenesis-mediated Cancer Metastasis’ (Meng Xie, Peking University Cancer Hospital).
CUKC, is an annual conference which focuses on discussing world-leading oncology research. The event brings together partners from the Cardiff China Medical Research Collaborative (CCMRC): Cardiff University, Peking University Cancer Hospital, Capital Medical University and Yiling Group.
This year’s CUKC Conference took place together with the 11th Chinese Gastric Cancer Congress (CGCC) and the 4th Sunlight Great Wall Cancer Academic Conference (SGWCAC) at the China National Convention Centre (CNCC) over three days.
Details for CUKC Conference 2017 will be released on the CUKC website shortly